Zaheed Husain

Title: Innovations and Contributions of Zaheed Husain

Introduction

Zaheed Husain is an accomplished inventor based in Medford, MA (US). He has made significant contributions to the field of cancer therapy and molecular biology, holding a total of three patents. His work focuses on innovative methods for treating cancer and improving genetic engineering techniques.

Latest Patents

One of Zaheed Husain's latest patents is centered on cancer therapy targeting intercellular adhesion molecule 4 (ICAM4). This invention outlines methods for treating cancer, particularly in conjunction with anti-cancer therapies such as immunotherapy. It also addresses the identification of candidate therapeutic agents by targeting ICAM4. Another notable patent is for pRGR, a positive selection vector system for direct cloning of PCR amplified DNA fragments. This invention involves the development of a cloning vector that carries a reporter gene or a regulatory gene with a mutation that renders it functionally inactive. By using a primer that corrects the mutation during PCR amplification, the wild-type reporter or regulatory gene can be reconstructed.

Career Highlights

Zaheed Husain has worked with several prominent organizations, including Synthegen Systems, Inc. and Beth Israel Deaconess Medical Center, Inc. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Some of his notable coworkers include Madhu Sudan Malo and Vikas P Sukhatme. Their collaboration has likely fostered an environment of innovation and shared knowledge in their respective fields.

Conclusion

Zaheed Husain's contributions to cancer therapy and molecular biology through his patents and collaborations highlight his role as a significant inventor in the scientific community. His work continues to pave the way for advancements in medical treatments and genetic engineering.